In hypoxic microenvironment, the TREM-1-expressing M2-like TAMs recruit CCR6-containing Tregs near liver cancer cells by secreting CCL20, which is the principal cause of resistance to anti-PD-L1 immunotherapy in liver cancer [101]. Here, TREM1 is linked to liver cancer.